Login | Register

MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA

Novartis says it has updated prescribing data for multiple sclerosis therapy Gilenya (Fingolimod) after a review by the Food and Drug Administration (FDA). The prescribing information includes new parameters for selecting patients, based on specific cardiovascular considerations...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *